Skip to main content

Table 1 The clinicopathological information of 40 RCC patients

From: Somatic mutations in renal cell carcinomas from Chinese patients revealed by targeted gene panel sequencing and their associations with prognosis and PD-L1 expression

Sample ID

Gender

Age

Subtype

Tumor grade

TNM stage

AJCC stagea

OS (months)

DFS (months)

Outcome

1

Male

76

ccRCC

G2

T3aN0M0

III

34

34

Death

2

Male

74

ccRCC

G2

T1aN0M0

I

32

32

Death

3

Male

31

ccRCC

G3

T3aN0M0

III

63

63

Death

4

Male

74

ccRCC

G2

T1aN0M0

I

62

62

Death

5

Male

54

ccRCC

G2

T1aN0M0

I

57

57

Death

6

Male

62

ccRCC

G2

T1aN0M0

I

76

64

Survival (metastasis)

7

Female

40

ccRCC

G3

T3bN0M0

III

74

24

Survival (metastasis)

8

Female

57

ccRCC

G2

T1aN0M0

I

74

24

Survival (metastasis)

9

Male

56

ccRCC

G2

T3aN0M0

III

72

9

Survival (metastasis)

10

Male

59

ccRCC

G3

T1bN0M0

I

71

12

Survival (metastasis)

11

Male

55

ccRCC

G1

T1bN0M0

I

74

74

Survival

12

Male

62

ccRCC

G2

T1bN0M0

I

74

74

Survival

13

Male

54

ccRCC

G2

T1aN0M0

I

74

74

Survival

14

Male

60

ccRCC

G2

T1bN0M0

I

74

74

Survival

15

Male

48

ccRCC

G1

T1aN0M0

I

74

74

Survival

16

Male

68

ccRCC

G2

T1bN0M0

I

73

73

Survival

17

Male

48

ccRCC

G2

T1aN0M0

I

73

73

Survival

18

Male

73

ccRCC

G1

T1aN0M0

I

73

73

Survival

19

Female

58

ccRCC

G2

T1aN0M0

I

72

72

Survival

20

Male

48

ccRCC

G2

T1aN0M0

I

72

72

Survival

21

Male

49

PRCC

G2

T2N0M0

II

15

15

Death

22

Female

66

PRCC

G2

T3aN1M0

III

37

37

Death

23

Male

70

PRCC

G2

T3aN0M0

III

66

66

Death

24

Male

63

PRCC

G2

T3bN0M0

III

29

29

Death

25

Male

65

PRCC

G2

T1aN0M0

I

49

49

Death

26

Female

22

PRCC

G1

T1aN0M0

I

76

76

Survival

27

Female

60

PRCC

G2

T1aN0M0

I

74

74

Survival

28

Male

69

PRCC

G2

T1aN0M0

I

73

73

Survival

29

Male

59

PRCC

G2

T1aN0M0

I

71

71

Survival

30

Male

58

PRCC

G2

T1aN0M0

I

69

69

Survival

31

Female

49

ChRCC

NA

T2N0M0

II

86

86

Survival

32

Male

64

ChRCC

NA

T1aN0M0

I

85

85

Survival

33

Female

37

ChRCC

NA

T1aN0M0

I

85

85

Survival

34

Male

36

ChRCC

NA

T1bN0M0

I

84

84

Survival

35

Female

54

ChRCC

NA

T1aN0M0

I

84

84

Survival

36

Female

52

ChRCC

NA

T1aN0M0

I

82

82

Survival

37

Female

75

ChRCC

NA

T1aN0M0

I

78

78

Survival

38

Male

40

ChRCC

NA

T1bN0M0

I

77

77

Survival

39

Female

36

ChRCC

NA

T1bN0M0

I

77

77

Survival

40

Female

49

ChRCC

NA

T1bN0M0

I

76

76

Survival

  1. RCC renal cell carcinoma, TNM tumor-node metastasis stage, AJCC American Joint Committee on Cancer, OS overall survival, DFS disease-free survival, ccRCC clear cell renal cell carcinoma, PRCC papillary renal cell carcinoma, ChRCC chromophobe renal cell carcinoma, NA not available
  2. aThe 7th edition of the AJCC Cancer Staging Manual was used
Back to article page

Cancer Communications

ISSN: 2523-3548

Contact us